WuXi Biologics (Cayman) Inc (WXXWY)
3.33
+0.06
(+1.74%)
USD |
OTCM |
Apr 17, 15:59
WuXi Biologics Cash from Investing (TTM): -725.15M for June 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | -725.15M |
| December 31, 2022 | -855.84M |
| June 30, 2022 | -648.12M |
| December 31, 2021 | -1.489B |
| June 30, 2021 | -1.679B |
| December 31, 2020 | -1.049B |
| June 30, 2020 | -1.001B |
| Date | Value |
|---|---|
| December 31, 2019 | -644.66M |
| June 30, 2019 | -349.46M |
| December 31, 2018 | -53.56M |
| June 30, 2018 | -221.32M |
| December 31, 2017 | -333.59M |
| June 30, 2017 | -68.61M |
| December 31, 2016 | -62.24M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.679B
Minimum
Jun 2021
-349.46M
Maximum
Jun 2019
-937.83M
Average
-855.84M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
| Wuxi AppTec Co Ltd | -1.069B |
| Zai Lab Ltd | -10.78M |
| I-MAB | -- |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Sinovac Biotech Ltd | -- |